Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
Forget Hantavirus and Ebola, this deadly virus has killed over 500, mostly children, in India's neighbouring country. Check signs and symptomsA severe measles outbreak in Bangladesh has claimed over 500 lives, predominantly young children, with over 60,000 suspected cases reported...
Hantavirus: Britain secures experimental Japanese drug to strengthen responseBritain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its ...
NHS England offers Covid booster: Last chance for adults under 50 to get booster jabNHS England offers Covid booster shot to adults under 50 in England will culminate in just over a week. If they haven't already, it is thei...
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR studyThe protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy ...
What's the difference in protection against Omicron between 2 doses and 3 doses of vaccine?Evidence had emerged suggesting the highly infectious Omicron variant has the ability to escape the protection two vaccine doses offer. So,...
8 vaccines, 4 treatments in India's COVID-19 arsenalMeanwhile, India logged 653 cases of the Omicron variant of coronavirus across 21 states and UTs so far out of which 186 have recovered or ...
Covid vaccinated people with prior infection may have more antibodies, says new studyFurther investigation is needed to determine whether increased post-vaccination durability in previously infected people is attributable to...
Sputnik V supply shortage hits government vaccination driveA source has said that several private hospitals have run out of the vaccine already. There have only been a few lakh doses available in th...
COVID: vaccine boosters are likely to increase protection against variants - new researchIn particular, past infection plus two doses of vaccine increased the chances of neutralising the beta and gamma variants. The level of neu...
Single dose of Sputnik V Covid vaccine triggers strong antibody response: StudyThe new study, published on Tuesday in the journal Cell Reports Medicine, examined whether a single dose would achieve greater public healt...
Covid-19 vaccine: Each vaccine vial, with 10 doses, must be used within 4 hours of openingFor instance, some vaccines under the Universal Immunisation Programme (UIP) can be used for about four weeks after the vial is opened (for...
New single-dose Ebola drug treatment developedThomas Geisbert from The University of Texas Medical Branch in the US said that previous therapeutics typically were of the "one bug, one d...
After India, other South East Asian countries opting for fractional doses of IPV: WHOWHO said that India became the first country globally to introduce fractional doses of IPV in childhood immunisation programme in eight sta...